Latest Apollo Projects

a collaboration with Prof John Trowsdale, University of Cambridge

By Richard Butt

a collaboration with Prof John Trowsdale, University of Cambridge

Prof Trowsdale has demonstrated Siglec-15 to be upregulated on a subset of tumour cells. A therapeutic mAb is hypothesized to be a useful therapeutic mechanism to either modify the tumour microenvironment to permit immune cell clearance of the tumour, or as a target for an ADC to directly kill the tumour cells. Based on this research Apollo and the Prof Trowsdale are developing novel mAb therapeutics.


|